Everolimus and other PI3K/Akt/mTOR inhibitors are known to induce autophagy in both solid and blood tumors [19, 20]; however, to our knowledge, this phenomenon has not been reported in breast cancer cells. This evidence concerns the gene AKT1 and hematopoietic and lymphoid system neoplasm.